Skip to content

Fluoxetine for reducing postoperative cognitive dysfunction in elderly patients undergoing total knee replacement

Fluoxetine for reducing postoperative cognitive dysfunction in elderly patients undergoing total knee replacement

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050424
Enrollment
Unknown
Registered
2021-08-27
Start date
2022-05-02
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Cognitive Dysfunction (POCD)

Interventions

Fluoxetine group:Take 20 mg fluoxetine orally, from 8 weeks before the surgery to one day before the surgery
Placebo group:Take placebo orally, from 8 weeks before the surgery to one day before the surgery.

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 65 years; 2. American Society of Anesthesiologists classification I-III.

Exclusion criteria

Exclusion criteria: 1. Minimal Mental State Examination (MMSE) score 3 times the upper limit of the standard) or renal damage (glomerular filtration rate <=60ml min^-1*1.73 m^-2). 7. Other investigators deem it inappropriate to be included in the study.

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative cognitive dysfunction;

Secondary

MeasureTime frame
Area under curve of NRS pain score (at rest and movement);The quailty of recovery after surgery;Incidence of postoperative delirium;Postoperative cumulative opioid consumption;Anxiety and depression;C-reactive protein;IL-1ß;Sleep;Hospitalisation time;

Countries

China

Contacts

Public ContactYao Yusheng

Fujian Provincial Hospital

fjslyys@126.com+86 1355993629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026